The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer

被引：0
|
作者：
Meghan Brennan
Paul Gass
Lothar Häberle
Daidong Wang
Arndt Hartmann
Michael P. Lux
Matthias W. Beckmann
Michael Untch
Peter A. Fasching
机构：
[1] University of California at Los Angeles,Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine
[2] University Hospital Erlangen,Department of Gynecology and Obstetrics
[3] Comprehensive Cancer Center Erlangen-EMN,Biostatistics Unit, Department of Gynecology and Obstetrics
[4] Friedrich-Alexander-University Erlangen-EMN,School of Public Heath, Biostatistics Department
[5] University Hospital Erlangen,Institute of Pathology
[6] University of California at Los Angeles,Department of Obstetrics and Gynecology
[7] University Hospital Erlangen,undefined
[8] Comprehensive Cancer Center Erlangen-EMN,undefined
[9] Friedrich- Alexander-University Erlangen-EMN,undefined
[10] Helios Klinikum Berlin-Buch,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词：
Breast cancer; Neoadjuvant therapy; Clinical trial participation; pCR; Mastectomy; Trial participation outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 758
页数：11
相关论文
共 50 条
  • [1] The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer
    Brennan, M. B.
    Wang, D.
    Gass, P.
    Hein, A.
    Beckmann, M. W.
    Fasching, P. A.
    CANCER RESEARCH, 2017, 77
  • [2] The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer
    Brennan, Meghan
    Gass, Paul
    Haeberle, Lothar
    Wang, Daidong
    Hartmann, Arndt
    Lux, Michael P.
    Beckmann, Matthias W.
    Untch, Michael
    Fasching, Peter A.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) : 747 - 758
  • [3] The effect of participation in RCT on outcomes in patients with early breast cancer compared to the general breast cancer population
    Brennan, Meghan B.
    Wiley, Dorothy
    Wang, Daidong
    Wang, Xiaoyan
    Fasching, Peter
    CANCER RESEARCH, 2018, 78 (04)
  • [4] NEOADJUVANT BREAST CANCER CLINICAL TRIALS IN AUSTRALIA
    Francis, Prudence A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 84 - 84
  • [5] Inclusivity of patients in early phase breast cancer clinical trials☆
    Sinha, A.
    Barwell, L.
    Jeffery, H.
    Peterson, Z.
    Shifa, B.
    Attia, M.
    Badawy, K.
    Purushotham, A.
    JOURNAL OF CANCER POLICY, 2024, 41
  • [6] Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists
    Ellis, PM
    Butow, PN
    Simes, RJ
    Tattersall, MHN
    Dunn, SM
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1999, 69 (07): : 486 - 491
  • [7] Does participation in clinical trials influence on survival in patients with metastatic breast cancer?
    Kim, T-Y
    Sohn, J. H.
    Kim, S-B
    Yoon, J. H.
    Kim, G. M.
    Lee, K. H.
    Koh, S-J
    Park, Y. H.
    Lee, S. E.
    Chae, Y.
    Lee, K. S.
    Lee, K. E.
    Won, H. S.
    Kim, J. H.
    Jeong, J.
    Park, K. H.
    Cho, E. K.
    Im, Y-H
    Im, S-A
    Jung, K. H.
    CANCER RESEARCH, 2016, 76
  • [8] Patient barriers to participation in breast cancer clinical trials
    Spears, Patricia A.
    BREAST CANCER MANAGEMENT, 2020, 9 (01)
  • [9] Clinical outcomes of neoadjuvant chemotherapy in HER2-low early breast cancer
    Gudelj, Dora
    Cular, Katarina
    Toula, Lea
    Krizic, Marija
    Popovic, Marina
    Plavetic, Natalija Dedic
    Kelecic, Ana
    Ivanac, Gordana
    Soce, Majana
    Gjergjaj, Iva Kukal
    Silovski, Tajana
    CANCER RESEARCH, 2024, 84 (09)
  • [10] Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy
    Keam, Bhumsuk
    Im, Seock-Ah
    Park, Sohee
    Nam, Byung-Ho
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Jee Hyun
    Lee, Se-Hoon
    Han, Wonshik
    Kim, Dong-Wan
    Kim, Tae-You
    Park, In Ae
    Noh, Dong-Young
    Heo, Dae Seog
    Bang, Yung-Jue
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (09) : 1301 - 1308
12345